NPHLA Intelligence
Clinical Trial Watch
Trials NPHLA follows, synchronised from ClinicalTrials.gov. We flag what matters (new registrations, changes in status and newly posted results) and ignore routine record edits. Every therapy in a trial is investigational.
- PAOLA: A Study of NT 201 Doses in the Treatment of Platysma Prominence
Merz Aesthetics GmbH. Conditions: Platysma Prominence. Results posted 2026-11-10. Investigational — not approved for the use studied.
- RHA®4 for Midface Volume Deficiency
Teoxane SA. Conditions: Cheek Augmentation; Correction of Age-related Midface Contour Deficiencies. Results posted 2025-03-18. Investigational — not approved for the use studied.
- Exosomes for Striae Distensae
Tanta University. Conditions: Striae Distensae. Investigational — not approved for the use studied.
- RICHER: A Non-Interventional PMCF Study Evaluating Croma Revitalis for the Correction of Fine Lines
Croma-Pharma GmbH. Conditions: Lateral Canthal Lines (LCL); Perioral Rhytids. Investigational — not approved for the use studied.
- Pilot Study of Combination Treatment With Subcision, Human Adipose Tissue-Derived Exosomes and Powdered Polydioxanone for Atrophic Acne Scars
COSMEDICIAN AP SDN BHD. Conditions: Atrophic Acne Scars. Investigational — not approved for the use studied.
- Constraint-induced Movement Therapy Versus Task-oriented Training On Upper Extremity Function Post-Botox Injection in Stroke Patients
Cairo University. Conditions: Constraint Induced Movement Therapy; Task Oriented Training; Botox Injection; Upper Extremity Function; Stroke. Investigational — not approved for the use studied.
- Comparative Study of The Efficacy and Safety of Subcision Combined With Injection of Exosomes Versus Subcision Alone in Treatment of Atrophic Post- Acne Scars.
Tanta University. Conditions: Acne Scars - Atrophic. Investigational — not approved for the use studied.
- Male Intimate Harmonization: Efficacy, Satisfaction, and Safety
Antony Barbosa Institute. Conditions: Male Intimate Harmonization Methods. Investigational — not approved for the use studied.
- Comparative Analysis of Intralesional Platelet-Rich Plasma, NPH Insulin, and Vitamin C- A New Horizon and Future Hope for Linear Atrophic Scar Management
Aya Ashraf Fouda. Conditions: Linear Atrophic Scars. Investigational — not approved for the use studied.
- Efficacy and Safety of CosmeRNA-ARI Anti Hair Loss Tonic in Adults With Androgenetic Alopecia
BIONEER Corporation. Conditions: Androgenetic Alopecia. Investigational — not approved for the use studied.
- NEUROQUIET: Botulinum Toxin Type A Versus Local Anesthetic Injection for Chronic Neuroma Pain After Combat-Related Amputation
Ukrainian Society of Regional Anesthesia and Pain Therapy. Conditions: Chronic Pain Due to Injury; Neuroma of Lower Limb; Neural Injury; Neuroma of Upper Limb; Combat Related Symptoms. Investigational — not approved for the use studied.
- MINOX: Treatment of Androgenetic Alopecia in Men for 24 Weeks
Eurofarma Laboratorios S.A.. Conditions: Alopecia. Investigational — not approved for the use studied.
- Pembro/IORT: Effects of MK-3475 (Pembrolizumab) on the Breast Tumor Microenvironment in Triple Negative Breast Cancer
Columbia University. Conditions: Triple Negative Breast Cancer. Investigational — not approved for the use studied.
- A Study of the Safety, Tolerability, and Efficacy of Topical SM04554 Solution in Male Subjects With Androgenetic Alopecia (AGA)
Biosplice Therapeutics, Inc.. Conditions: Androgenetic Alopecia. Results posted 2026-10-01. Investigational — not approved for the use studied.
- Safety, Pharmacokinetics and Efficacy of PP405 in Adults With AGA
Pelage Pharmaceuticals, Inc.. Conditions: Androgenetic Alopecia. Results posted 2026-09-22. Investigational — not approved for the use studied.
- Fractional CO₂ Laser Combined With Topical Plant-Derived Exosomes Versus Non-Cross-Linked Hyaluronic Acid for Atrophic Acne Scars
October 6 University. Conditions: Atrophic Acne Scar. Investigational — not approved for the use studied.
- A Study to Assess Safety and Effectiveness of HArmonyCa Lidocaine Injectable Gel for Restoration and/or Creation of Mid-Face Volume in Adult Participants
AbbVie. Conditions: Mid Face Volume Deficit. Investigational — not approved for the use studied.
- A Study Evaluating the Efficacy and Safety of SM04554 Topical Solution in Male Subjects With Androgenetic Alopecia
Biosplice Therapeutics, Inc.. Conditions: Androgenetic Alopecia. Results posted 2026-10-01. Investigational — not approved for the use studied.
- A Study of SM04554 Applied Topically to the Scalp of Male Subjects With Androgenetic Alopecia Analyzed by Biopsy of the Scalp Prior To and Post Dosing
Biosplice Therapeutics, Inc.. Conditions: Androgenetic Alopecia. Results posted 2026-10-01. Investigational — not approved for the use studied.
- AnteAGE Exosomes and PEARL Multiplier With Microneedling for Facial Skin Quality
Cellese Inc.. Conditions: Skin Aging; Skin Quality. Investigational — not approved for the use studied.
- AnteAGE Biosomes With Radiofrequency Microneedling for Facial Skin Rejuvenation
Cellese Inc.. Conditions: Skin Aging; Facial Rhytides; Skin Tone. Investigational — not approved for the use studied.
- A Study to Assess Adverse Events of Intramuscular AGN-151586 Injection in Adult Participants With Glabellar Lines
AbbVie. Conditions: Glabellar Lines. Results posted 2026-09-25. Investigational — not approved for the use studied.
- Treatment of Peyronie's Disease With Platelet-Rich Plasma
Herlev Hospital. Conditions: Peyronies Disease. Investigational — not approved for the use studied.
- Topical Rifamycin SV for Wound Healing After Sapphire FUE Hair Transplantation
Elif Asena KANTARCI. Conditions: Androgenetic Alopecia; Wound Healing. Investigational — not approved for the use studied.
- Effectiveness of Platelet-rich Plasma Treatment of Knee Osteoarthritis
Universidad Nacional de Entre Rios. Conditions: Knee Osteoarthritis. Investigational — not approved for the use studied.
- Topical Multivitamin Serum for Skin Heath
Erevna Innovations Inc.. Conditions: Aesthetic. Investigational — not approved for the use studied.
- AGA: PRP Combined With Botulinum Toxin Type A Injection for the Treatment of Androgenetic Alopecia: A Study
Nanfang Hospital, Southern Medical University. Conditions: Androgenetic Alopecia (AGA). Investigational — not approved for the use studied.
- A Study to Investigate the Safety and Efficacy of YY003 in Adults With Moderate to Severe Glabellar Lines
Chongqing Claruvis Pharmaceutical Co., Ltd.. Conditions: Moderate to Severe Glabellar Lines. Investigational — not approved for the use studied.
- Umbilical Cord Mesenchymal Stem Cell-Derived Exosomes in the Treatment of Androgenic Alopecia
Fujian Medical University Union Hospital. Conditions: Androgenic Alopecia. Investigational — not approved for the use studied.
- AI-09 In Subjects With Glabellar Lines, GL-101
Eirion Therapeutics Inc.. Conditions: Glabellar Frown Lines. Results posted 2026-08-31. Investigational — not approved for the use studied.
- MMP US P3 416: A Study to Assess BOTOX Injections in Adult Participants for the Change of Masseter Muscle Prominence
AbbVie. Conditions: Masseter Muscle Prominence. Investigational — not approved for the use studied.
- EXO-MINO: Exosome Injection Versus Topical Minoxidil for Androgenetic Alopecia
Tanta University. Conditions: Androgenetic Alopecia; Exosomes. Investigational — not approved for the use studied.
- MMP US P3 417: A Study to Assess BOTOX Injections for the Change of Masseter Muscle Prominence in Adult Participants
AbbVie. Conditions: Masseter Muscle Prominence. Investigational — not approved for the use studied.
- Zinc Supplementation Prior to Botox Injections for Spasmodic Dysphonia
University of Florida. Conditions: Spasmodic Dysphonia. Results posted 2026-07-27. Investigational — not approved for the use studied.
- Botulinum Toxin Type A Versus Cross-Linked Hyaluronic Acid Filler Myomodulation for Non-Surgical Management of Excessive Gingival Display
Al-Azhar University. Conditions: Excessive Gingival Display; Gingival Diseases; Gummy Smile; Esthetics, Dental. Investigational — not approved for the use studied.
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Trial listings are not recommendations to enrol or prescribe.